ID   2C4 [Mouse hybridoma against human ERBB2]
AC   CVCL_B0EI
SY   2c4
DR   ATCC; HB-12697
DR   Wikidata; Q108819512
RX   Patent=US10280228;
RX   PubMed=1689212;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12697.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=US10280228;
RA   Baughman S.A., Shak S.;
RT   "Treatment with anti-ErbB2 antibodies.";
RL   Patent number US10280228, 07-May-2019.
//
RX   PubMed=1689212;
RA   Fendly B.M., Winget M., Hudziak R.M., Lipari M.T., Napier M.A.,
RA   Ullrich A.;
RT   "Characterization of murine monoclonal antibodies reactive to either
RT   the human epidermal growth factor receptor or HER2/neu gene product.";
RL   Cancer Res. 50:1550-1558(1990).
//